Mutations in MYO9B are associated with Charcot-Marie-Tooth disease type 2 neuropathies and isolated optic atrophy.

MLA

Cipriani, Silvia, et al. “Mutations in MYO9B Are Associated with Charcot-Marie-Tooth Disease Type 2 Neuropathies and Isolated Optic Atrophy.” European Journal of Neurology, vol. 30, no. 2, Feb. 2023, pp. 511–26. EBSCOhost, https://doi.org/10.1111/ene.15601.

APA

Cipriani, S., Guerrero-Valero, M., Tozza, S., Zhao, E., Vollmer, V., Beijer, D., Danzi, M., Rivellini, C., Lazarevic, D., Pipitone, G. B., Grosz, B. R., Lamperti, C., Marzoli, S. B., Carrera, P., Devoto, M., Pisciotta, C., Pareyson, D., Kennerson, M., Previtali, S. C., … Bolino, A. (2023). Mutations in MYO9B are associated with Charcot-Marie-Tooth disease type 2 neuropathies and isolated optic atrophy. European Journal of Neurology, 30(2), 511–526. https://doi.org/10.1111/ene.15601

Chicago

Cipriani, Silvia, Marta Guerrero-Valero, Stefano Tozza, Edward Zhao, Veith Vollmer, Danique Beijer, Matt Danzi, et al. 2023. “Mutations in MYO9B Are Associated with Charcot-Marie-Tooth Disease Type 2 Neuropathies and Isolated Optic Atrophy.” European Journal of Neurology 30 (2): 511–26. doi:10.1111/ene.15601.